Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 2

Status

Completed 5Terminated 1

Sponsor Class

OTHER 8NETWORK 6NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 8Breast 6Other solid neoplasm 1Head & Neck 1

Conditions

Breast Neoplasms 5Sleep Wake Disorders 1Fatigue 1Breast Cancer Invasive Nos 1

Interventions

Cyclophosphamide 42Docetaxel 33Paclitaxel 31Tamoxifen 29Doxorubicin 29Trastuzumab 25Radiotherapy 21Epirubicin 16Letrozole 15Anastrozole 12exemestane 11Fluorouracil 11Capecitabine 10Bevacizumab 10palbociclib 9Immunohistochemistry 9Fulvestrant 9Filgrastim 9Lapatinib 8Zoledronic Acid 7Methotrexate 7Magnetic Resonance Spectroscopy 7Gene Expression Profiling 7pertuzumab 6Triptorelin Pamoate 6Taxes 6Surgical Procedures, Operative 6Microarray Analysis 6Goserelin 6Chemotherapy, Adjuvant 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
NETWORK × Triptorelin Pamoate × Breast × Clear all
NCT05896566 2026-02-24

PREcoopERA

ETOP IBCSG Partners Foundation

Phase 2 Completed
231 enrolled
Breast

Breast Neoplasms

NCT00066690 2026-02-06

SOFT

ETOP IBCSG Partners Foundation

Phase 3 Completed
3,066 enrolled 15 charts
Breast

Breast Neoplasms

NCT00066703 2026-02-06

TEXT

ETOP IBCSG Partners Foundation

Phase 3 Completed
2,672 enrolled 14 charts
Breast

Breast Neoplasms

NCT02005887 2019-05-29

TREND

ETOP IBCSG Partners Foundation

Phase 2 Completed
51 enrolled 10 charts
Breast

Breast Cancer Invasive Nos

NCT00066807 2016-10-28

PERCHE

ETOP IBCSG Partners Foundation

Phase 3 Terminated
29 enrolled 6 charts
Breast

Breast Neoplasms

NCT00659373 2016-07-25

Co-SOFT

ETOP IBCSG Partners Foundation

Phase 3 Completed
86 enrolled 4 charts
Breast

Breast Neoplasms, Fatigue, Sleep Wake Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡